SCL:NYE-Stepan Company (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 78.06

Change

0.00 (0.00)%

Market Cap

USD 1.78B

Volume

0.27M

Analyst Target

USD 123.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Stepan Co, along with its subsidiaries produces specialty and intermediate chemicals, which are sold to other manufacturers and are used in end products. The Company manufactures & markets surfactants, polymers and specialty products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-03 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
APD Air Products and Chemicals Inc

N/A

USD 59.74B
LYB LyondellBasell Industries NV

N/A

USD 32.09B
PPG PPG Industries Inc

N/A

USD 30.27B
DLY DoubleLine Yield Opportunities..

N/A

USD 27.84B
ALB Albemarle Corp

N/A

USD 9.04B
AXTA Axalta Coating Systems Ltd

N/A

USD 7.58B
ESI Element Solutions Inc

N/A

USD 6.05B
FUL H B Fuller Company

N/A

USD 4.40B
ASH Ashland Global Holdings Inc

N/A

USD 4.15B
AVNT Avient Corp

N/A

USD 4.12B

ETFs Containing SCL

EDIV:PA Lyxor S&P Eurozone ESG Di.. 4.70 % 0.00 %

N/A

N/A
ZPD9:XETRA SPDR® S&P® Euro Dividen.. 4.69 % 0.00 %

N/A

USD 6.13M
EUDIV:PA Lyxor S&P Eurozone ESG Di.. 4.03 % 0.00 %

N/A

N/A
CACM:PA Lyxor UCITS CAC Mid 60 D-.. 3.46 % 0.00 %

N/A

USD 0.01B
FEUZ:LSE First Trust Eurozone Alph.. 1.27 % 0.00 %

N/A

USD 0.06B
FEUD:LSE First Trust Eurozone Alph.. 1.27 % 0.00 %

N/A

USD 0.02B
FEUZ First Trust Eurozone Alph.. 0.00 % 0.80 %

N/A

USD 0.06B
FTEU:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

N/A

USD 0.06B
FTGE:XETRA First Trust Eurozone Alph.. 0.00 % 0.00 %

N/A

USD 0.08B
EDIV:LSE Lyxor S&P Eurozone ESG Di.. 0.00 % 0.00 %

N/A

USD 0.13B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.44% 29% F 11% F
Dividend Return 0.79% 35% F 22% F
Total Return -16.65% 27% F 11% F
Trailing 12 Months  
Capital Gain -16.64% 28% F 14% F
Dividend Return 1.59% 43% F 25% F
Total Return -15.05% 28% F 13% F
Trailing 5 Years  
Capital Gain -16.98% 23% F 27% F
Dividend Return 6.91% 27% F 21% F
Total Return -10.07% 21% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain -1.25% 28% F 32% F
Dividend Return -0.03% 24% F 27% F
Total Return 1.22% 36% F 28% F
Risk Return Profile  
Volatility (Standard Deviation) 19.54% 85% B 52% F
Risk Adjusted Return -0.17% 24% F 27% F
Market Capitalization 1.78B 54% F 67% D+

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.20 4% 11%
Price/Book Ratio 1.55 56% 51%
Price / Cash Flow Ratio 11.64 50% 33%
Price/Free Cash Flow Ratio 14.57 30% 27%
Management Effectiveness  
Return on Equity 3.16% 26% 38%
Return on Invested Capital 3.56% 21% 40%
Return on Assets 1.86% 26% 47%
Debt to Equity Ratio 32.98% 83% 70%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.